Trials / Recruiting
RecruitingNCT05286034
Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme
Artificial Intelligence-assisted Decision-making to Improve Women's Participation to Cervical Cancer Screening in Occitanie Region-France
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,000 (estimated)
- Sponsor
- International Agency for Research on Cancer · Academic / Other
- Sex
- Female
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This project looks to improve the return rate of HPV self-sampling (HPVss) as well as the management of women HPVss positive.
Detailed description
France has already implemented a cervical screening programme based on HPV test for the whole female population aged 30-65 years. Non-participant women can perform HPV test at their home. However, less than 20% of French women performed vaginal self-sampling when a kit was sent to their home. Women with lower income and educational levels participate less to cervical screening. A variety of personal, practitioner, test-related and logistical barriers negatively impact the screening participation of French women. Key barriers to participation could be addressed by overcoming disparities in HPV-related knowledge and perceptions about cervical cancer screening. This study aims to evaluate the impact of sending HPV self-sampling kit at women's home, associated with providing, through multiple mobile channels, a multi-language decision aid designed for women with lower education accessible via artificial intelligence-based ChatBot. This decision aid will help women review high quality evidence on cervical cancer disease and screening modalities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Decision aid tailored to women with lower educational attainment,accessible via artificial intelligence-based Chatbot platforms | Non-compliant women those that have not been screened for more than 4 years and living in the disadvantaged areas will be sent screening reminder letters to perform HPV self-sampling (HPVss) test, with access to decision aid tailored to women with lower education attainment and available via Chatbot platforms. ChatBot will deliver information in a responsive, conversational way via text and spoken language in multiple languages through multiple mobile channels. |
Timeline
- Start date
- 2025-11-03
- Primary completion
- 2026-07-31
- Completion
- 2026-08-18
- First posted
- 2022-03-18
- Last updated
- 2026-03-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05286034. Inclusion in this directory is not an endorsement.